Unknown

Dataset Information

0

The evolution of strategies to minimise the risk of human drug-induced liver injury (DILI) in drug discovery and development.


ABSTRACT: Early identification of toxicity associated with new chemical entities (NCEs) is critical in preventing late-stage drug development attrition. Liver injury remains a leading cause of drug failures in clinical trials and post-approval withdrawals reflecting the poor translation between traditional preclinical animal models and human clinical outcomes. For this reason, preclinical strategies have evolved over recent years to incorporate more sophisticated human in vitro cell-based models with multi-parametric endpoints. This review aims to highlight the evolution of the strategies adopted to improve human hepatotoxicity prediction in drug discovery and compares/contrasts these with recent activities in our lab. The key role of human exposure and hepatic drug uptake transporters (e.g. OATPs, OAT2) is also elaborated.

SUBMITTER: Walker PA 

PROVIDER: S-EPMC7395068 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

The evolution of strategies to minimise the risk of human drug-induced liver injury (DILI) in drug discovery and development.

Walker Paul A PA   Ryder Stephanie S   Lavado Andrea A   Dilworth Clive C   Riley Robert J RJ  

Archives of toxicology 20200506 8


Early identification of toxicity associated with new chemical entities (NCEs) is critical in preventing late-stage drug development attrition. Liver injury remains a leading cause of drug failures in clinical trials and post-approval withdrawals reflecting the poor translation between traditional preclinical animal models and human clinical outcomes. For this reason, preclinical strategies have evolved over recent years to incorporate more sophisticated human in vitro cell-based models with mult  ...[more]

Similar Datasets

| S-EPMC8380240 | biostudies-literature
| S-EPMC7702310 | biostudies-literature
| S-EPMC9227129 | biostudies-literature
| S-EPMC8184702 | biostudies-literature
| S-EPMC9164935 | biostudies-literature
| S-EPMC7814730 | biostudies-literature
| S-EPMC7254069 | biostudies-literature
| S-EPMC8000729 | biostudies-literature
2022-07-01 | MSV000089782 | MassIVE
| S-EPMC5747433 | biostudies-literature